fda compounding semaglutide enforcement news today 2025 is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger to protect patients from unverified The FDA should require negative

04, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company, today shared new real-world findings from tens of thousands of members, showing a clear relationship: members who engage more with Nooms leading GL

Fat-Melting Furnace Formula: InnoSlim, Paradoxine, and Rauwolscine work together to turn stored fat into energy, igniting your metabolism and targeting stubborn fat

With GlucoVantage (Bioactive Berberine), probiotics, and colostrum, we're addressing the common side effects of GLP-1 medications to help individuals feel their best on their weight management journey

The correct dosage of retatrutide depends on individual health conditions, treatment goals, and medical supervision

Learn the signs, treatment options and how to respond in an emergency.

GLP1 adoption is expanding, but a startstop user base is accelerating existing shifts in how consumers eat and how food brands innovate, according to Numerator.